Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology

Yuanyuan Zhong,Lingli Hu,Wenjing Chen,Bin Wang,Jing Sun,Jingcheng Dong
DOI: https://doi.org/10.1186/s12906-022-03637-7
IF: 4.782
2022-06-10
BMC Complementary and Alternative Medicine
Abstract:Asthma and idiopathic pulmonary fibrosis (IPF) are common chronic diseases of the respiratory system in clinical practice. However, the relationship and molecular links remain unclear, and the current treatment's efficacy is disappointing. Bu-Shen-Yi-Qi (BSYQ) decoction has proven effective in treating various chronic airway inflammatory diseases, including asthma and IPF. But the underlying pharmacological mechanisms are still to be elucidated.
What problem does this paper attempt to address?